# FDA recall D-0650-2017

> **Lupin Pharmaceuticals Inc.** · Class III · drug recall initiated 2015-12-07.

## Product

Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09

## Reason for recall

Failed Impurities/Degradation Specifications; Impurity A

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0650-2017
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-12-07
- **Report date:** 2017-04-12
- **Termination date:** 2017-04-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0650-2017

## Citation

> AI Analytics. FDA recall D-0650-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0650-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*